Epidemiology of hepatitis C virus in Korea

被引:52
作者
Shin, HR [1 ]
机构
[1] Natl Canc Ctr, Res Inst Natl Canc & Evaluat, Div Canc Control & Epidemiol, Goyang 411769, Gyeonggi Do, South Korea
关键词
epidemiology; genotypes; hepatitis C virus; Korea; transfusion;
D O I
10.1159/000087258
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mortality due to liver cancer in Korea ranks as one of the highest in the world. Both hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are high-risk factors for liver cancer. Although HBV is by far the more important risk factor for the development of hepatocellular carcinoma (HCC) in Korea, HCV infection is more closely associated with HCC in elderly patients. Therefore, the evaluation of risk factors for HCV infection, including blood transfusion, is important. This study reviews the literature on HCV prevalence and risk factors among the general population, as well as the distribution of HCV genotypes in Korea. An overall estimate of the prevalence of anti-HCV among Koreans older than 40 years was 1.29% (95% confidence interval 1.12-1.48) during 1995-2000. Blood transfusion was the strongest risk factor for transmission of HCV infection. Risk factors for HCV infection in Korea other than blood transfusion and history of acupuncture have not been proven. The most prevalent HCV genotype is 1b followed by 2a. Even though the prevalence of anti-HCV in Korea has been reduced and the risk of HCV transmission through blood transfusion has markedly decreased, public-health programs to prevent de novo infections should be developed. Moreover, most people infected with HCV in Korea are older than 40 years, and therefore, the surveillance of adults (>= 40 years) for HCV infection will be helpful in early detection of HCC developing in them. Copyright (C) 2006 S. Karger AG, Basel.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 34 条
[1]  
ALTER MJ, 1997, HEPATOLOGY S1, V26, P62
[2]   Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity [J].
Markus Backmund ;
Kirsten Meyer ;
Martin Wächtler ;
Dieter Eichenlaub .
European Journal of Epidemiology, 2003, 18 (6) :563-568
[3]  
Han Chul Ju, 1997, Korean Journal of Internal Medicine (English Edition), V12, P21
[4]  
Jeong TH, 1998, J KOREAN ACAD FAM ME, V19, P364
[5]  
JU YH, 2004, IN PRESS KOREAN J PR
[6]  
Kemp R, 1998, NEW ZEAL MED J, V111, P50
[7]   GENOTYPE DISTRIBUTION AND COMPARISON OF THE PUTATIVE ENVELOPE REGION OF HEPATITIS-C VIRUS FROM KOREAN PATIENTS [J].
KIM, CJ ;
SHIN, KS ;
KIM, WY ;
LIM, DS ;
YOON, SK ;
PARK, YM ;
KIN, BS ;
JANG, SK ;
CHO, MJ .
JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (04) :380-386
[8]   Seroprevalence of sexually transmitted viruses in Korean populations including HIV-seropositive individuals [J].
Kim, O ;
Kim, SS ;
Park, MS ;
Suh, SD ;
Lee, MW ;
Kim, KS ;
Yoon, JD ;
Lee, JS .
INTERNATIONAL JOURNAL OF STD & AIDS, 2003, 14 (01) :46-49
[9]  
KIM SY, 1997, J KOREAN ACAD FAM ME, V18, P1508
[10]  
Kim WS, 1995, J PUSAN MED ASS, V31, P18